Critical issues emerging from current attempts at inducing transplantation tolerance in the clinic include the need for biomarkers that predict and diagnose tolerance as well as for the identification of barriers to tolerance induction and maintenance. Our preliminary observations have led us to the realization that the durability of the tolerant state is variable and can be unpredictably breached by Listeria infections. The overall goal of the proposed studies Is to determine a mechanistic basis for how Infections can either erode or transiently abrogate robust tolerance after It has been stably established. We propose 3 specific aims:
Specific Aim 1 : Our investigations to date have determined that the abrogation of established tolerance by Listeria infection is mechanistically different from the prevention of tolerance induction, and that the combination of IL-6 and IFNU is necessary and sufficient to abrogate established tolerance. We will conduct mechanistic studies to determine how the combination of IL-6 and IFNB abrogates established tolerance.
Specific Aim 2 : Approximately 25% of tolerant recipients infected with Listeria do not reject their grafts. However, this retained state of tolerance acquires susceptibility to reversal by PDL-1 blockade, whereas tolerance prior to Listeria infection does not. We will determine the mechanistic bases for these observations, and test whether other infections such as Staphylococcus aureus and influenza, that cannot precipitate rejection in recipients with established tolerance, can nonetheless erode the quality of tolerance and make it increasingly susceptible to reversal.
Specific Aim 3 : Our investigations have recently revealed an unexpected resilience of the state of transplantation tolerance. Infection with Listeria only transiently subsumes the tolerant state but tolerance spontaneously returns after the infection is cleared. We will define why and how tolerance is spontaneously restored when infection with Listeria is cleared. We anticipate that these studies will provide novel and clinically relevant insights into how tolerance to allografts is maintained, abrogated and potentially restorable. Our studies may also lead to the identification of biomarkers for the diagnosis and assessment of the quality of tolerance, and to the definition of therapies that can maintain and """"""""boost"""""""" the quality of tolerance. Finally, we speculate that studies on how tolerance is transiently lost but spontaneously re-established might reveal fundamental principles of how T cell responses are regulated not only in transplantation tolerance but also in autoimmunity and in the recurrence of cancers.
(Relevance) Successful induction of transplantation tolerance for achieving long-term allograft survival has been reported in a number of preclinical models and in limited clinical scenarios. 777e overall goal of the proposed studies Is to determine a mechanistic basis for how infections with Listeria and other Infections erode or abrogate tolerance after It has been well and stably established through co-stimulation blockade. Insights gained from these studies may lead to new approaches for establishing, maintaining and restoring the state of tolerance in transplantation.
|Khiew, Stella H; Yang, Jinghui; Young, James S et al. (2017) CTLA4-Ig in combination with FTY720 promotes allograft survival in sensitized recipients. JCI Insight 2:|
|Chong, Anita S (2017) Alone Again, Naturally: B Cells Encountering Antigen Without T cells. Transplantation 101:1956-1958|
|Young, James S; McIntosh, Christine; Alegre, Maria-Luisa et al. (2017) Evolving Approaches in the Identification of Allograft-Reactive T and B Cells in Mice and Humans. Transplantation 101:2671-2681|
|Miller, Michelle L; Alegre, Maria-Luisa; Chong, Anita S (2017) Transplantation tolerance after allograft rejection. Curr Opin Organ Transplant 22:64-70|
|Young, J S; Daniels, M D; Miller, M L et al. (2017) Erosion of Transplantation Tolerance After Infection. Am J Transplant 17:81-90|
|Lei, Yuk Man; Chen, Luqiu; Wang, Ying et al. (2016) The composition of the microbiota modulates allograft rejection. J Clin Invest 126:2736-44|
|Alegre, Maria-Luisa; Lakkis, Fadi G; Morelli, Adrian E (2016) Antigen Presentation in Transplantation. Trends Immunol 37:831-843|
|Young, J S; Chen, J; Miller, M L et al. (2016) Delayed Cytotoxic T Lymphocyte-Associated Protein 4-Immunoglobulin Treatment Reverses Ongoing Alloantibody Responses and Rescues Allografts From Acute Rejection. Am J Transplant 16:2312-23|
|Miller, M L; Chen, J; Daniels, M D et al. (2016) Adoptive Transfer of Tracer-Alloreactive CD4+T Cell Receptor Transgenic T Cells Alters the Endogenous Immune Response to an Allograft. Am J Transplant 16:2842-2853|
|Yang, Jinghui; Chen, Jianjun; Young, James S et al. (2016) Tracing Donor-MHC Class II Reactive B cells in Mouse Cardiac Transplantation: Delayed CTLA4-Ig Treatment Prevents Memory Alloreactive B-Cell Generation. Transplantation 100:1683-91|
Showing the most recent 10 out of 27 publications